Document Classification

Section Type: METHODS

Text: Sixty healthy women who had been postmenopausal for 1 to 5 years were recruited and divided into following 4 groups : group 1, percutaneous gel 17beta-estradiol (E (2)) 1. 5 mg/d plus micronized progesterone (MP) 100 mg/d ; group 2, percutaneous gel 17beta-estradiol (E (2)) 1. 5 mg/d plus medroxyprogesterone acetate (MPA) 2 mg/d ; group 3, percutaneous gel 17beta-estradiol (E (2)) 0. 75 mg/d plus micronized progesterone (MP) 100 mg/d ; and group 4, percutaneous gel 17beta-estradiol (E (2)) 0. 75 mg/d plus medroxyprogesterone acetate (MPA) 2 mg/d.